Alinsug, Jose .

HRN: 28-60-07  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/17/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
02/17/2026
02/24/2026
IV
2.25G
Q6H
SEPSIS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: